Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly-Reference-Cited by-同舟云学术

Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly

Published:2019-05 Issue: Volume:43 Page:537-552
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Chenlo Miguel^ORCID,Rodriguez-Gomez Iria A.,Serramito Ramon,Garcia-Rendueles Angela R.,Villar-Taibo Rocío,Fernandez-Rodriguez Eva,Perez-Romero Sihara,Suarez-Fariña Maria,Garcia-Allut Alfredo,Cabezas-Agricola Jose M.,Rodriguez-Garcia Javier,Lear Pamela V.,Alvarez-San Martin Rosa M.,Alvarez-Escola Cristina,Bernabeu Ignacio,Alvarez Clara V.^ORCID

Funder

Instituto Investigación Carlos III

PFIZER_Investigator Initiated Research (IIR) Program

PFIZER Foundation

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference71 articles.

1. The prevalence of pituitary adenomas: a systematic review;Ezzat;Cancer,2004

2. Landscape of familial isolated and young-onset pituitary adenomas: prospective diagnosis in AIP mutation carriers;Hernández-Ramírez;J Clin Endocrinol Metab,2015

3. Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities;Pivonello;Pituitary,2017